Stratos Wealth Partners, Ltd. Guardant Health, Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$109.77 - $165.68 $163,447 - $246,697	-1,489 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$127.04 - $179.1 $109,762 - $154,742	-864 Reduced 36.72%	1,489 $227,000
Q4 2020 Jan 29, 2021	SELL	$99.96 - $135.93 $4,998 - $6,796	-50 Reduced 2.08%	2,353 $303,000
Q3 2020 Oct 29, 2020	BUY	$80.32 - $111.8 $193,008 - $268,655	2,403 New	2,403 $269,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.64B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.